Key Event Components

  • Key Event Components (KECs) are used to describe Key Events (KEs) in a computable way, by defining an action, processes, and object term that maps to controlled vocabulary and ontology terms.
  • KECs on this page can be filtered by the action, process, and object terms, as well as by source ontologies.
  • Link to source ontology terms are provided in cases where the URL was available when the ontology terms were added to the AOP-Wiki database.
  • A complete list of all KECs is available in TSV format on the Downloads Page.
Showing 251 to 275 of 1160 KECs
Clear Table Filters
ID Action Process Object Associated Key Events (KEs)
910 increased glutathione binding (GO:0043295) glutathione conjugate (CHEBI:24335) 2131: Conjugation, GSH
909 occurrence viral entry into host cell (GO:0046718) viral protein (PR:000036197) 1738: SARS-CoV-2 cell entry
908 occurrence viral entry into host cell (GO:0046718) viral genome (GO:0019015) 1738: SARS-CoV-2 cell entry
907 decreased second-messenger-mediated signaling (GO:0019932) sonic hedgehog protein (PR:000014841) 2043: Decrease, Sonic Hedgehog second messenger production
906 decreased sonic hedgehog protein (PR:000014841) None
905 increased endocrine signaling (GO:0038002) estrone (CHEBI:17263) 2092: Promotion, Ovarian Cancer
904 increased goblet cell (CL:0000160) 2117: Increase, goblet cell number
903 decreased T cell activation involved in immune response (GO:0002286) T cell (CL:0000084) 1702: Suppression of T cell activation
902 increased eye opacity (MP:0009859) Lens (FMA:58241) 2083: Occurrence of Cataracts
901 functional change nitric oxide homeostasis (GO:0033484) endothelium (UBERON:0001986) 2067: Altered, Nitric Oxide Levels
900 occurrence blood vessel remodeling (GO:0001974) blood vessel (UBERON:0001981) 2069: Occurrence, Abnormal Vascular Remodeling
899 occurrence Blood vessel (FMA:63183) None
898 decreased decreased triiodothyronine level (MP:0005473) 3,3',5'-triiodothyronine (CHEBI:28774) 1003: Decreased, Triiodothyronine (T3)
897 decreased protein localization to cilium (GO:0061512) smoothened (PR:000015288) 2044: Decrease, Smoothend relocation and activation
896 decreased second-messenger-mediated signaling (GO:0019932) None
895 increased cleft upper lip (MP:0005170) 2042: Increase, Orofacial clefting
894 increased Cleft palate (HP:0000175) 2042: Increase, Orofacial clefting
893 decreased abnormal palatal shelf fusion at midline (MP:0009887) secondary palate (UBERON:0001716) None
892 decreased palatal shelves fail to meet at midline (MP:0009888) primary palate (UBERON:0005620) None
891 decreased secondary palatal shelf (UBERON:0005619) None
890 decreased gene expression (GO:0010467) zinc finger protein GLI2 (PR:000008027) 2040: Decrease, GLI1/2 target gene expression
889 decreased gene expression (GO:0010467) zinc finger protein GLI1 (PR:000008026) 2040: Decrease, GLI1/2 target gene expression
888 decreased gene expression (GO:0010467)
887 increased gene expression (GO:0010467)
886 decreased protein import into nucleus, translocation (GO:0000060) zinc finger protein GLI2 (PR:000008027) 2028: Decrease, GLI1/2 translocation to nucleus